focus -WSS

focus

author：fashion 2025-08-26 10:54:39 - browse：61639

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How I ended up pumping milk in a bathroom stall at JPM 2024

WSS

New menopause drug shows promise in relief for hot flashes

Empower primary care with adequate payments and technology

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

DeSantis can now import cheaper drugs. But will Biden get credit?

BIO to announce reorganization, senior leaders expected to depart

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

leisure time

focus

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

As JPM 2024 winds down, some health tech firms project optimism

Heart attack and stroke risk calculators need revising

The effects of a landmark ruling on DNA ownership are becoming clearer

The cancer drug shortage isn’t new — and neither are the solutions

The creative science of coining drug names

Wildfire smoke exposes gaps in outdoor worker protections

How I ended up pumping milk in a bathroom stall at JPM 2024

Medical records are filled with copy

Most antidepressants don't work on kids, teens, study finds

knowledge

Brain MRIs reveal impact of 'toxic stress' on Black children

AltruBio raises $225 million to develop ulcerative colitis drug

As billionaires fund anti

Empower primary care with adequate payments and technology

Generative AI mines health records to identify patients’ social needs

Most antidepressants don't work on kids, teens, study finds

focus

entertainment

hotspot

Wikipedia